Zephyrnet Logo

Nasal spray to prevent COVID infection begins clinical trials

Date:

The spray was developed to both prevent the virus infecting nasal cells in the first place and to reduce viral transmission in those already with COVID-19

An innovative clinical trial is set to commence in Australia testing whether a common blood thinning drug can prevent SARS-CoV-2 infection. The drug is administered by nasal spray and researchers believe it can block the virus from initially infecting cells in the nose.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: Coronavirus (COVID-19), New Atlas Audio

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://newatlas.com/health-wellbeing/nasal-spray-heparin-coronavirus-infection-clinical-trial/

spot_img

Latest Intelligence

spot_img